Standout Papers
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (2011)
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment (2011)
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) (2014)
Immediate Impact
1 from Science/Nature 188 standout
Citing Papers
Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
2023 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
2020 Standout
Works of Christopher C. Nessel being referenced
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
2014
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Christopher C. Nessel | 10561 | 5289 | 1656 | 72 | 11.2k | |
| Marco Alings | 12486 | 5468 | 1925 | 84 | 13.6k | |
| Jun Zhu | 9628 | 3869 | 1640 | 132 | 10.9k | |
| John F. Paolini | 7841 | 3762 | 1545 | 84 | 10.2k | |
| Amit Parekh | 7961 | 3744 | 1282 | 28 | 8.7k | |
| Ron Pisters | 8894 | 2769 | 1646 | 53 | 9.6k | |
| Werner Hacke | 12620 | 5961 | 2737 | 115 | 14.2k | |
| Ellison Themeles | 9420 | 3944 | 1494 | 15 | 10.2k | |
| Paul Reilly | 15327 | 7602 | 2302 | 123 | 17.0k | |
| Jyotsna Garg | 6861 | 3084 | 1740 | 22 | 9.7k | |
| Denis Xavier | 10426 | 4771 | 1734 | 100 | 13.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...